Adequate dietary calcium mitigates osteopenia induced by chronic lead exposure in adult rats

Mineral and Electrolyte Metabolism

Volumn 25, Issue 3, 1999, Pages 143-146

  Gruber, Helen E ^a   Ding, Yaoxian ^b   Stasky, Audrey A ^a   Meyer, Martha ^a   Pandian, Murugan R ^c   Pandian, Deepa ^b   Vaziri, Nosratola D ^b   Grigsby, Jared ^a   Gonick, Harvey C ^d,e  

^a LEVINE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Corning Nichols Institute Laboratory ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1,25 Dihydroxyvitamin D parathyroid hormone; Bone; Calcium intake; Lead; Mineral metabolism

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; LEAD; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERAL; CALCIUM BONE LEVEL; CALCIUM INTAKE; CONTROLLED STUDY; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; HISTOLOGY; LEAD POISONING; MALE; MORPHOMETRICS; NONHUMAN; OSTEOPENIA; PRIORITY JOURNAL; RAT;

ANIMALS; BONE AND BONES; BONE DISEASES, METABOLIC; CALCIUM, DIETARY; CHRONIC DISEASE; LEAD POISONING; MALE; MINERALS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0032792166     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057438     Document Type: Article

References (16)

1. Gruber HE, Gonick HC, Khalil-Manesh F, Sanchez TV, Motsinger S, Meyer M, Sharp CF: Osteopenia induced by long-term, low and high-level exposure of the adult rat to lead. Miner Electrolyte Metab 1997;23:65-73.
2. Mylorie AA, Moore L, Olyai B, Anderson M: Increased susceptibility of lead toxicity in rats fed semipurified diets. Environ Res 1978;15:57-64.
3. Smothers RL, Valenzuela YL, White MH, Witte CL: Effect of lead administration on 25-hydroxy-vitamin D 1-alpha-hydroxylase in the rat kidney (abstract). J Bone Miner Res 1989;4(suppl 1):s298.
4. Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R, Bergamaschi E, Mutti A, Rosen VJ: Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 1992;41:1192-1203.
5. 3 metabolism in experimental lead intoxication. European J Clin Invest 1991;21:512-520.
6. Matkovic V, Kostial K, Simonovic R, Buzina R, Brodarec A, Nordin BEC: Bone status and fracture rate in two regions of Yugoslavia. Am J Clin Nutr 1979;32:540-549.
7. Heaney RP: Calcium intake and bone health in the adult. Clin Appl Nutr 1992;2:10-29.
8. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327: 1637-1642.
9. Fullmer CS: Intestinal interactions of lead and calcium. Neurotoxicology 1992;13:799-808.
10. Mahaffey KR, Rader JI: Metabolic interactions: Lead, calcium, and ion. Ann N Y Acad Sci 1980;355:285-297.
11. Pounds JG: Effects of lead intoxication on calcium homeostasis and calcium-mediated cell function: A review. Neurotoxicology 1984;5: 295-332.
12. Barton JC, Conrad ME, Harrison L, Nuby S: Effects of calcium on the absorption and retention of lead. J Lab Clin Med 1978;91:366-376.
13. Quaterman J, Morrison JN: The effects of dietary calcium and phosphorus on the retention and excretion of lead in rats. Br J Nutr 1975; 34:351-362.
14. Goyer RA: Calcium and lead interaction: Some new insights. J Lab Clin Med 1978;91:363-365.
15. Mahaffey KR, Rosen JF, Chesney RW, Peeler JT, Smith CM, DeLuca HF: Association between age, blood lead concentration, and serum 1,25-dihydroxycholecalciferol levels in children. Am J Clin Nutr 1982;35:1327-1331.
16. Schanne FAX, Gupta RK, Rosen JF: Lead inhibits 1,25-dihydroxyvitamin D-3 regulation of calcium metabolism in osteoblastic osteosarcoma cells (ROS 17/2.8). Biochim Biophys Acta 1992;1180:187-194.